Current Rheumatology Reports

, Volume 10, Issue 4, pp 295–296

The comparative effectiveness of methotrexate and anti-tumor necrosis factor therapy in psoriatic arthritis

  • Christopher T. Ritchlin
Clinical Trials Report


  1. 1.
    O’Dell JR: Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004, 350: 2591–2602.PubMedCrossRefGoogle Scholar
  2. 2.
    Heydendael VMR, Spuls PI, Opmeer BC, et al.: Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 2003, 349: 658–665.PubMedCrossRefGoogle Scholar
  3. 3.
    Black R, Obrien W, Vanscott E, et al.: Methotrexate therapy in psoriatic arthritis, double-blind study in 21 patients. JAMA 1964, 189: 743–747.PubMedGoogle Scholar
  4. 4.
    Willkens RF, Williams HJ, Ward JR, et al.: Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 1984, 27: 376–381.PubMedCrossRefGoogle Scholar
  5. 5.
    Soriano ER, McHugh NJ: Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J Rheumatol 2006, 33: 1422–1430.PubMedGoogle Scholar
  6. 6.
    Kavanaugh AF, Ritchlin CT, the GRAPPA Treatment Guidelines Committee: Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J Rheumatol 2006, 33: 1417–1421.PubMedGoogle Scholar
  7. 7.
    Kane D, Stafford L, Bresnihan B, FitzGerald O: A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003, 42: 1460–1468.PubMedCrossRefGoogle Scholar
  8. 8.
    Heiberg MS, Koldingsnes W, Mikkelsen K, et al.: The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study. Arthritis Rheum 2008, 59: 234–240.PubMedCrossRefGoogle Scholar
  9. 9.
    Klareskog L, van der Heijde D, de Jager JP, et al.: Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004, 363: 675–681.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Christopher T. Ritchlin

There are no affiliations available

Personalised recommendations